Publications

Immune Checkpoint Ligand PD-L1 is upregulated in Pulmonary LAM
August 2018

Guidelines for the diagnosis and management of Lymphangioleiomyomatosis
LAM Research Paper from the European Respiratory Society
January 2010

Feasibility of Immunotherapy for Lymphangioleiomyomatosis 
published in The American Journal of Pathology 
November 2009

Melanoma–Associated Antigen Expression in Lymphangioleiomyomatosis Renders Tumor Cells Susceptible to Cytotoxic T Cells 
published in The American Journal of Pathology 
November 2009

Molecular Pathogenesis of Lymphangioleiomyomatosis 
December 2007

Selected LAM publications from 2003-2007

Pleural Disease in Lymphangioleiomyomatosis
Khalid F. Almoosa, MDa,T, Francis X. McCormack, MDa, Steven A. Sahn, MDb
2006

Advances in Lymphangioleiomyomatosis
by Francis X McCormack, MD; and Lisa Young, MD
2006

Lymphangioleiomyomatosis 
Angelo M. Taveira-DaSilva, MD, PhD, Wendy K. Steagall, PhD, and Joel Moss, MD, PhD
October 2006

Lymphangioleiomyomatosis
MedGenMed Pulmonary Medicine
Francis X. McCormack, MD
January 2006

The NHLBI Lymphangioleiomyomatosis Registry
Characteristics of 230 Patients at Enrollment
September 2005

Survival and disease progression in UK patients with lymphangioleiomyomatosis
S R Johnson, C I Whale, R B Hubbard, S A Lewis, A E Tattersfield
May 2004

Lymphangioleiomyomatosis
Series “RARE INTERSTITIAL LUNG DISEASES”
Edited by C. Vogelmeier and U. Costabel Number 1 in this Series S.R. Johnson
March 2004